标题
Antineoplastic Drug-Induced Cardiotoxicity: A Redox Perspective
作者
关键词
-
出版物
Frontiers in Physiology
Volume 9, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2018-03-07
DOI
10.3389/fphys.2018.00167
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- ROS signalling in the biology of cancer
- (2018) Jennifer N. Moloney et al. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
- Mitochondrial reactive oxygen species are involved in chemoattractant-induced oxidative burst and degranulation of human neutrophils in vitro
- (2017) Nina Vorobjeva et al. EUROPEAN JOURNAL OF CELL BIOLOGY
- Multidisciplinary Approach to Novel Therapies in Cardio-Oncology Research (MANTICORE 101–Breast): A Randomized Trial for the Prevention of Trastuzumab-Associated Cardiotoxicity
- (2017) Edith Pituskin et al. JOURNAL OF CLINICAL ONCOLOGY
- Prevention and Monitoring of Cardiac Dysfunction in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline
- (2017) Saro H. Armenian et al. JOURNAL OF CLINICAL ONCOLOGY
- Are Mast Cells MASTers in Cancer?
- (2017) Gilda Varricchi et al. Frontiers in Immunology
- European contribution to the study of ROS: A summary of the findings and prospects for the future from the COST action BM1203 (EU-ROS)
- (2017) Javier Egea et al. Redox Biology
- From Molecular Mechanisms to Clinical Management of Antineoplastic Drug-Induced Cardiovascular Toxicity: A Translational Overview
- (2017) Carlo Gabriele Tocchetti et al. ANTIOXIDANTS & REDOX SIGNALING
- Elevated plasma levels of vascular permeability factors in C1 inhibitor-deficient hereditary angioedema
- (2016) S. Loffredo et al. ALLERGY
- Anti-PD-1 therapy in patients with advanced melanoma and preexisting autoimmune disorders or major toxicity with ipilimumab
- (2016) A. M. Menzies et al. ANNALS OF ONCOLOGY
- New signal transduction paradigms in anthracycline-induced cardiotoxicity
- (2016) Alessandra Ghigo et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- TAS-102, the first “cardio-gentle” fluoropyrimidine in the colorectal cancer landscape?
- (2016) Fausto Petrelli et al. BMC CANCER
- Prevention of cardiac dysfunction during adjuvant breast cancer therapy (PRADA): a 2 × 2 factorial, randomized, placebo-controlled, double-blind clinical trial of candesartan and metoprolol
- (2016) Geeta Gulati et al. EUROPEAN HEART JOURNAL
- 2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines
- (2016) Jose Luis Zamorano et al. EUROPEAN HEART JOURNAL
- 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
- (2016) Piotr Ponikowski et al. EUROPEAN JOURNAL OF HEART FAILURE
- Controversial role of mast cells in skin cancers
- (2016) Gilda Varricchi et al. EXPERIMENTAL DERMATOLOGY
- Current views on anthracycline cardiotoxicity
- (2016) Donato Mele et al. HEART FAILURE REVIEWS
- Models of Heart Failure Based on the Cardiotoxicity of Anticancer Drugs
- (2016) Valentina Mercurio et al. JOURNAL OF CARDIAC FAILURE
- Preventing antiblastic drug-related cardiomyopathy
- (2016) Christian Cadeddu et al. Journal of Cardiovascular Medicine
- Pathophysiology of anthracycline cardiotoxicity
- (2016) Donato Mele et al. Journal of Cardiovascular Medicine
- Role of biomarkers in monitoring antiblastic cardiotoxicity
- (2016) Giuseppina Novo et al. Journal of Cardiovascular Medicine
- Cardioprotective effects of inorganic nitrate/nitrite in chronic anthracycline cardiotoxicity: Comparison with dexrazoxane
- (2016) Olga Lenčová-Popelová et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Cardiac cytochrome c and cardiolipin depletion during anthracycline-induced chronic depression of mitochondrial function
- (2016) Gonçalo C. Pereira et al. MITOCHONDRION
- Combination chemoprevention with grape antioxidants
- (2016) Chandra K. Singh et al. MOLECULAR NUTRITION & FOOD RESEARCH
- NOX4-dependent fatty acid oxidation promotes NLRP3 inflammasome activation in macrophages
- (2016) Jong-Seok Moon et al. NATURE MEDICINE
- Fulminant Myocarditis with Combination Immune Checkpoint Blockade
- (2016) Douglas B. Johnson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Novel Perspectives in Redox Biology and Pathophysiology of Failing Myocytes: Modulation of the Intramyocardial Redox Milieu for Therapeutic Interventions—A Review Article from the Working Group of Cardiac Cell Biology, Italian Society of Cardiology
- (2016) Alessia Arcaro et al. Oxidative Medicine and Cellular Longevity
- Does the Interdependence between Oxidative Stress and Inflammation Explain the Antioxidant Paradox?
- (2016) Subrata Kumar Biswas Oxidative Medicine and Cellular Longevity
- VEGF-B gene therapy inhibits doxorubicin-induced cardiotoxicity by endothelial protection
- (2016) Markus Räsänen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The immune network in thyroid cancer
- (2016) Maria Rosaria Galdiero et al. OncoImmunology
- Angiotensin II–Receptor Inhibition With Candesartan to Prevent Trastuzumab-Related Cardiotoxic Effects in Patients With Early Breast Cancer
- (2016) Annelies H. Boekhout et al. JAMA Oncology
- ErbB2 overexpression upregulates antioxidant enzymes, reduces basal levels of reactive oxygen species, and protects against doxorubicin cardiotoxicity
- (2015) Frances Belmonte et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Redox signalling and cardioprotection: translatability and mechanism
- (2015) P Pagliaro et al. BRITISH JOURNAL OF PHARMACOLOGY
- Pharmacology of the ‘gasotransmitters’ NO, CO and H2S: translational opportunities
- (2015) Andreas Papapetropoulos et al. BRITISH JOURNAL OF PHARMACOLOGY
- Chronic Statin Administration May Attenuate Early Anthracycline-Associated Declines in Left Ventricular Ejection Function
- (2015) Runyawan Chotenimitkhun et al. CANADIAN JOURNAL OF CARDIOLOGY
- Bidirectional cross-regulation between ErbB2 and β-adrenergic signalling pathways
- (2015) Polina Sysa-Shah et al. CARDIOVASCULAR RESEARCH
- Early Detection of Anthracycline Cardiotoxicity and Improvement With Heart Failure Therapy
- (2015) D. Cardinale et al. CIRCULATION
- Nitroso-Redox Balance and Modulation of Basal Myocardial Function: An Update from the Italian Society of Cardiovascular Research (SIRC)
- (2015) Carlo Tocchetti et al. CURRENT DRUG TARGETS
- Cardiac endothelium–myocyte interaction: clinical opportunities for new heart failure therapies regardless of ejection fraction
- (2015) Shir Lynn Lim et al. EUROPEAN HEART JOURNAL
- Pathophysiological role of oxidative stress in systolic and diastolic heart failure and its therapeutic implications
- (2015) Thomas Münzel et al. EUROPEAN HEART JOURNAL
- Oxidative stress alters global histone modification and DNA methylation
- (2015) Yingmei Niu et al. FREE RADICAL BIOLOGY AND MEDICINE
- Improving the preclinical models for the study of chemotherapy-induced cardiotoxicity: a Position Paper of the Italian Working Group on Drug Cardiotoxicity and Cardioprotection
- (2015) Rosalinda Madonna et al. HEART FAILURE REVIEWS
- Cardioprotection by gene therapy
- (2015) Rosalinda Madonna et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Tyrosine Kinase Inhibitor–Associated Cardiovascular Toxicity in Chronic Myeloid Leukemia
- (2015) Javid J. Moslehi et al. JOURNAL OF CLINICAL ONCOLOGY
- ROS and RNS in plant physiology: an overview
- (2015) Luis A. del Río JOURNAL OF EXPERIMENTAL BOTANY
- Human lung-resident macrophages express CB1 and CB2 receptors whose activation inhibits the release of angiogenic and lymphangiogenic factors
- (2015) Rosaria I. Staiano et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Intracoronary Cytoprotective Gene Therapy
- (2015) Felix Woitek et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- ERBB2 triggers mammalian heart regeneration by promoting cardiomyocyte dedifferentiation and proliferation
- (2015) Gabriele D’Uva et al. NATURE CELL BIOLOGY
- Chronic heart damage following doxorubicin treatment is alleviated by lovastatin
- (2015) Christian Henninger et al. PHARMACOLOGICAL RESEARCH
- Cancer after intense and prolonged antiplatelet therapies – fact or fiction?
- (2015) Raffaele De Caterina THROMBOSIS AND HAEMOSTASIS
- Recent Advances on Pathophysiology, Diagnostic and Therapeutic Insights in Cardiac Dysfunction Induced by Antineoplastic Drugs
- (2015) Marilisa Molinaro et al. Biomed Research International
- Redox regulation of genome stability by effects on gene expression, epigenetic pathways and DNA damage/repair
- (2015) Yuliya Mikhed et al. Redox Biology
- Exercise Prevention of Cardiovascular Disease in Breast Cancer Survivors
- (2015) Amy A. Kirkham et al. Journal of Oncology
- Effort myocardial ischemia during chemotherapy with 5-fluorouracil: an underestimated risk
- (2014) C. Lestuzzi et al. ANNALS OF ONCOLOGY
- New Redox-Related Arrows in the Arsenal of Cardiac Disease Treatment
- (2014) Jonathan A. Kirk et al. ANTIOXIDANTS & REDOX SIGNALING
- Cardiotoxicity of systemic agents used in breast cancer
- (2014) Felipe Ades et al. BREAST
- Evaluation of lecithinized human recombinant super oxide dismutase as cardioprotectant in anthracycline-treated breast cancer patients
- (2014) Frederik J. F. Broeyer et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Angiogenesis and Cardiac Hypertrophy
- (2014) Toru Oka et al. CIRCULATION RESEARCH
- VEGF-B-induced vascular growth leads to metabolic reprogramming and ischemia resistance in the heart
- (2014) Riikka Kivelä et al. EMBO Molecular Medicine
- Ranolazine protects from doxorubicin-induced oxidative stress and cardiac dysfunction
- (2014) Carlo G. Tocchetti et al. EUROPEAN JOURNAL OF HEART FAILURE
- Protein S-nitrosylation in preconditioning and postconditioning
- (2014) Claudia Penna et al. EXPERIMENTAL BIOLOGY AND MEDICINE
- Conquests and perspectives of cardio-oncology in the field of tumor angiogenesis-targeting tyrosine kinase inhibitor-based therapy
- (2014) Giuseppe Bronte et al. Expert Opinion On Drug Safety
- Cardiotoxicity of doxorubicin is mediated through mitochondrial iron accumulation
- (2014) Yoshihiko Ichikawa et al. JOURNAL OF CLINICAL INVESTIGATION
- Mitochondrial reactive oxygen species production and elimination
- (2014) Alexander Nickel et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Docetaxel plus nintedanib versus docetaxel plus placebo in patients with previously treated non-small-cell lung cancer (LUME-Lung 1): a phase 3, double-blind, randomised controlled trial
- (2014) Martin Reck et al. LANCET ONCOLOGY
- Anthracycline-induced cardiotoxicity: Overview of studies examining the roles of oxidative stress and free cellular iron
- (2014) Tomáš Šimůnek et al. Pharmacological Reports
- Oxaliplatin Neurotoxicity Involves Peroxisome Alterations. PPARγ Agonism as Preventive Pharmacological Approach
- (2014) Matteo Zanardelli et al. PLoS One
- A mechanistic study on the cardiotoxicity of 5-fluorouracil in vitro and clinical and occupational perspectives
- (2014) Monica Lamberti et al. TOXICOLOGY LETTERS
- Anti‐Remodeling and Anti‐Fibrotic Effects of the Neuregulin‐1β Glial Growth Factor 2 in a Large Animal Model of Heart Failure
- (2014) Cristi L. Galindo et al. Journal of the American Heart Association
- Cancer Therapy–Induced Cardiotoxicity: Basic Mechanisms and Potential Cardioprotective Therapies
- (2014) Virginia Shalkey Hahn et al. Journal of the American Heart Association
- The role of iron in anthracycline cardiotoxicity
- (2014) Elena Gammella et al. Frontiers in Pharmacology
- A systematic review of the pathophysiology of 5-fluorouracil-induced cardiotoxicity
- (2014) Anne Polk et al. BMC Pharmacology & Toxicology
- Redox-Optimized ROS Balance and the relationship between mitochondrial respiration and ROS
- (2013) Sonia Cortassa et al. BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS
- The role of antioxidants in the era of cardio-oncology
- (2013) Duncan T. Vincent et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Cardiotoxicity in cancer patients treated with 5-fluorouracil or capecitabine: A systematic review of incidence, manifestations and predisposing factors
- (2013) Anne Polk et al. CANCER TREATMENT REVIEWS
- 5-fluorouracil induced cardiotoxicity: Review of the literature
- (2013) Michael F. Sorrentino et al. Cardiology Journal
- Emerging Paradigms in Cardiomyopathies Associated With Cancer Therapies
- (2013) Bonnie Ky et al. CIRCULATION RESEARCH
- Cardioprotective Effect of β-Adrenoceptor Blockade in Patients With Breast Cancer Undergoing Chemotherapy
- (2013) Sinziana Seicean et al. Circulation-Heart Failure
- Role of cardioprotective therapy for prevention of cardiotoxicity with chemotherapy: A systematic review and meta-analysis
- (2013) Kashif Kalam et al. EUROPEAN JOURNAL OF CANCER
- The emerging issue of cardiac dysfunction induced by antineoplastic angiogenesis inhibitors
- (2013) Carlo G. Tocchetti et al. EUROPEAN JOURNAL OF HEART FAILURE
- The beneficial effects of tadalafil on left ventricular dysfunction in doxorubicin-induced cardiomyopathy
- (2013) Zhe Jin et al. Journal of Cardiology
- Recent molecular discoveries in angiogenesis and antiangiogenic therapies in cancer
- (2013) Jonathan Welti et al. JOURNAL OF CLINICAL INVESTIGATION
- MicroRNA-25-dependent up-regulation of NADPH oxidase 4 (NOX4) mediates hypercholesterolemia-induced oxidative/nitrative stress and subsequent dysfunction in the heart
- (2013) Zoltán V. Varga et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Enalapril and Carvedilol for Preventing Chemotherapy-Induced Left Ventricular Systolic Dysfunction in Patients With Malignant Hemopathies
- (2013) Xavier Bosch et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Axitinib versus sorafenib as first-line therapy in patients with metastatic renal-cell carcinoma: a randomised open-label phase 3 trial
- (2013) Thomas E Hutson et al. LANCET ONCOLOGY
- Anthracyclines and Heart Failure
- (2013) Douglas B. Sawyer NEW ENGLAND JOURNAL OF MEDICINE
- Proteotoxicity and Cardiac Dysfunction — Alzheimer's Disease of the Heart?
- (2013) Monte S. Willis et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pazopanib versus Sunitinib in Metastatic Renal-Cell Carcinoma
- (2013) Robert J. Motzer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cardiac Tolerability of Pertuzumab Plus Trastuzumab Plus Docetaxel in Patients With HER2-Positive Metastatic Breast Cancer in CLEOPATRA: A Randomized, Double-Blind, Placebo-Controlled Phase III Study
- (2013) S. M. Swain et al. ONCOLOGIST
- Creatine Kinase-Overexpression Improves Myocardial Energetics, Contractile Dysfunction and Survival in Murine Doxorubicin Cardiotoxicity
- (2013) Ashish Gupta et al. PLoS One
- Coronary Microvascular Pericytes Are the Cellular Target of Sunitinib Malate-Induced Cardiotoxicity
- (2013) V. Chintalgattu et al. Science Translational Medicine
- Exercise Therapy as Treatment for Cardiovascular and Oncologic Disease After a Diagnosis of Early-Stage Cancer
- (2013) Jessica M. Scott et al. SEMINARS IN ONCOLOGY
- Long-term, up to 18 months, protective effects of the angiotensin II receptor blocker telmisartan on Epirubin-induced inflammation and oxidative stress assessed by serial strain rate
- (2013) Mariele Dessì et al. SpringerPlus
- Cardiovascular toxicity induced by chemotherapy, targeted agents and radiotherapy: ESMO Clinical Practice Guidelines
- (2012) G. Curigliano et al. ANNALS OF ONCOLOGY
- Oxidative Stress, Redox Signaling, and Metal Chelation in Anthracycline Cardiotoxicity and Pharmacological Cardioprotection
- (2012) Martin Štěrba et al. ANTIOXIDANTS & REDOX SIGNALING
- NADPH Oxidases in Heart Failure: Poachers or Gamekeepers?
- (2012) Min Zhang et al. ANTIOXIDANTS & REDOX SIGNALING
- Role of HMGB1 in doxorubicin-induced myocardial apoptosis and its regulation pathway
- (2012) Yongwei Yao et al. BASIC RESEARCH IN CARDIOLOGY
- Sunitinib causes dose-dependent negative functional effects on myocardium and cardiomyocytes
- (2012) Peter P. Rainer et al. BJU INTERNATIONAL
- Increased expression of microRNA-146a decreases myocardial ischaemia/reperfusion injury
- (2012) Xiaohui Wang et al. CARDIOVASCULAR RESEARCH
- Personal Omics Profiling Reveals Dynamic Molecular and Medical Phenotypes
- (2012) Rui Chen et al. CELL
- Late Sodium Current Inhibition Reverses Electromechanical Dysfunction in Human Hypertrophic Cardiomyopathy
- (2012) Raffaele Coppini et al. CIRCULATION
- Neuregulin in Cardiovascular Development and Disease
- (2012) Oghenerukevwe Odiete et al. CIRCULATION RESEARCH
- Biomarkers of Protein Oxidation in Human Disease
- (2012) A. Garcia-Garcia et al. CURRENT MOLECULAR MEDICINE
- Cancer drugs and the heart: importance and management
- (2012) T. M. Suter et al. EUROPEAN HEART JOURNAL
- Protective effects of nebivolol against anthracycline-induced cardiomyopathy: A randomized control study
- (2012) Mehmet G. Kaya et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Effect of Statin Therapy on the Risk for Incident Heart Failure in Patients With Breast Cancer Receiving Anthracycline Chemotherapy
- (2012) Sinziana Seicean et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Risk of Heart Failure in Breast Cancer Patients After Anthracycline and Trastuzumab Treatment: A Retrospective Cohort Study
- (2012) E. J. A. Bowles et al. JNCI-Journal of the National Cancer Institute
- Identification of the molecular basis of doxorubicin-induced cardiotoxicity
- (2012) Sui Zhang et al. NATURE MEDICINE
- Dietary inorganic nitrate alleviates doxorubicin cardiotoxicity: Mechanisms and implications
- (2012) Lei Xi et al. NITRIC OXIDE-BIOLOGY AND CHEMISTRY
- Role of antioxidants in cancer therapy
- (2012) Vanessa Fuchs-Tarlovsky NUTRITION
- Continuous Versus Bolus Infusion of Doxorubicin in Children With ALL: Long-term Cardiac Outcomes
- (2012) S. E. Lipshultz et al. PEDIATRICS
- Incidence and Risk of QTc Interval Prolongation among Cancer Patients Treated with Vandetanib: A Systematic Review and Meta-analysis
- (2012) Jiajie Zang et al. PLoS One
- Toll-Like Receptor (TLR) 2 and TLR4 Differentially Regulate Doxorubicin Induced Cardiomyopathy in Mice
- (2012) Yonggang Ma et al. PLoS One
- Capecitabine (and 5 Fluorouracil) Cardiotoxicity. Metabolic Considerations
- (2011) Chiara Lestuzzi et al. Breast Journal
- Global cancer statistics
- (2011) Ahmedin Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- 5-Fluorouracil-based therapy induces endovascular injury having potential significance to development of clinically overt cardiotoxicity
- (2011) Søren Astrup Jensen et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Therapeutic effects of neuregulin-1 in diabetic cardiomyopathy rats
- (2011) Bingong Li et al. Cardiovascular Diabetology
- Clinical and Electrocardiography Changes in Patients Treated with Capecitabine
- (2011) Dogan Koca et al. CHEMOTHERAPY
- Effects of Novel Angiogenesis Inhibitors for the Treatment of Cancer on the Cardiovascular System
- (2011) Babak Nazer et al. CIRCULATION
- Modulation of Anthracycline-Induced Cardiotoxicity by Aerobic Exercise in Breast Cancer
- (2011) Jessica M. Scott et al. CIRCULATION
- Mechanisms of Antiangiogenic-Induced Arterial Hypertension
- (2011) Jean-Jacques Mourad et al. CURRENT HYPERTENSION REPORTS
- Anthracycline cardiotoxicity
- (2011) Pierantonio Menna et al. Expert Opinion On Drug Safety
- Creatine kinase–mediated improvement of function in failing mouse hearts provides causal evidence the failing heart is energy starved
- (2011) Ashish Gupta et al. JOURNAL OF CLINICAL INVESTIGATION
- Randomized, Placebo-Controlled, Phase III Study of Oxaliplatin, Fluorouracil, and Leucovorin With or Without PTK787/ZK 222584 in Patients With Previously Treated Metastatic Colorectal Adenocarcinoma
- (2011) Eric Van Cutsem et al. JOURNAL OF CLINICAL ONCOLOGY
- Efficacy and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or early HER2-positive breast cancer (NeoSphere): a randomised multicentre, open-label, phase 2 trial
- (2011) Luca Gianni et al. LANCET ONCOLOGY
- Pertuzumab plus Trastuzumab plus Docetaxel for Metastatic Breast Cancer
- (2011) José Baselga et al. NEW ENGLAND JOURNAL OF MEDICINE
- Platinum-Based Compounds and Risk for Cardiovascular Toxicity in the Elderly: Role of the Antioxidants in Chemoprevention
- (2011) Patrizia Ferroni et al. REJUVENATION RESEARCH
- Vascular Endothelial Growth Factor Stimulates Endothelial Colony Forming Cells Proliferation and Tubulogenesis by Inducing Oscillations in Intracellular Ca2+ Concentration
- (2011) Silvia Dragoni et al. STEM CELLS
- Inhibition of Rac1 signaling by lovastatin protects against anthracycline-induced cardiac toxicity
- (2011) J Huelsenbeck et al. Cell Death & Disease
- Long-term protective effects of the angiotensin receptor blocker telmisartan on epirubicin-induced inflammation, oxidative stress and myocardial dysfunction
- (2011) MARIELE DESSÌ et al. Experimental and Therapeutic Medicine
- Protective effects of the angiotensin II receptor blocker telmisartan on epirubicin-induced inflammation, oxidative stress, and early ventricular impairment
- (2010) Christian Cadeddu et al. AMERICAN HEART JOURNAL
- Reduced in vivo high-energy phosphates precede Adriamycin-induced cardiac dysfunction
- (2010) M. Y. Maslov et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Cardioprotective Pathways During Reperfusion: Focus on Redox Signaling and Other Modalities of Cell Signaling
- (2010) Pasquale Pagliaro et al. ANTIOXIDANTS & REDOX SIGNALING
- Nitric Oxide/Reactive Oxygen Species Generation and Nitroso/Redox Imbalance in Heart Failure: From Molecular Mechanisms to Therapeutic Implications
- (2010) Chiara Nediani et al. ANTIOXIDANTS & REDOX SIGNALING
- Redox-optimized ROS balance: A unifying hypothesis
- (2010) M.A. Aon et al. BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS
- Nox2 NADPH Oxidase Promotes Pathologic Cardiac Remodeling Associated with Doxorubicin Chemotherapy
- (2010) Y. Zhao et al. CANCER RESEARCH
- Acute doxorubicin cardiotoxicity is associated with miR-146a-induced inhibition of the neuregulin-ErbB pathway
- (2010) Takahiro Horie et al. CARDIOVASCULAR RESEARCH
- Juvenile Exposure to Anthracyclines Impairs Cardiac Progenitor Cell Function and Vascularization Resulting in Greater Susceptibility to Stress-Induced Myocardial Injury in Adult Mice
- (2010) Chengqun Huang et al. CIRCULATION
- Vascular Endothelial Growth Factor-B Acts as a Coronary Growth Factor in Transgenic Rats Without Inducing Angiogenesis, Vascular Leak, or Inflammation
- (2010) Maija Bry et al. CIRCULATION
- Elevated Cytosolic Na + Increases Mitochondrial Formation of Reactive Oxygen Species in Failing Cardiac Myocytes
- (2010) Michael Kohlhaas et al. CIRCULATION
- Molecular Mechanisms of Cardiovascular Toxicity of Targeted Cancer Therapeutics
- (2010) Hui Cheng et al. CIRCULATION RESEARCH
- The Vulnerability of the Heart As a Pluricellular Paracrine Organ
- (2010) Gilles W. De Keulenaer et al. CIRCULATION RESEARCH
- Parenteral administration of recombinant human neuregulin-1 to patients with stable chronic heart failure produces favourable acute and chronic haemodynamic responses
- (2010) Andrew Jabbour et al. EUROPEAN JOURNAL OF HEART FAILURE
- Cardiovascular side effects of cancer therapies: a position statement from the Heart Failure Association of the European Society of Cardiology
- (2010) Thomas Eschenhagen et al. EUROPEAN JOURNAL OF HEART FAILURE
- Troponin I Provides Insight Into Cardiotoxicity and the Anthracycline-Trastuzumab Interaction
- (2010) Michael S. Ewer et al. JOURNAL OF CLINICAL ONCOLOGY
- Long-Acting Phosphodiesterase-5 Inhibitor Tadalafil Attenuates Doxorubicin-Induced Cardiomyopathy without Interfering with Chemotherapeutic Effect
- (2010) S. Koka et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- A Phase II, Randomized, Double-Blind, Multicenter, Based on Standard Therapy, Placebo-Controlled Study of the Efficacy and Safety of Recombinant Human Neuregulin-1 in Patients With Chronic Heart Failure
- (2010) Runlin Gao et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Initial Assessment, Surveillance, and Management of Blood Pressure in Patients Receiving Vascular Endothelial Growth Factor Signaling Pathway Inhibitors
- (2010) Michael L. Maitland et al. JNCI-Journal of the National Cancer Institute
- Doxorubicin pathways
- (2010) Caroline F. Thorn et al. Pharmacogenetics and Genomics
- Doxorubicin In Vivo Rapidly Alters Expression and Translation of Myocardial Electron Transport Chain Genes, Leads to ATP Loss and Caspase 3 Activation
- (2010) Amy V. Pointon et al. PLoS One
- The lack of target specificity of small molecule anticancer kinase inhibitors is correlated with their ability to damage myocytes in vitro
- (2010) Brian B. Hasinoff et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- 5-FU Metabolism in Cancer and Orally-Administrable 5-FU Drugs
- (2010) Koh Miura et al. Cancers
- Intricacies of Bevacizumab-Induced Toxicities and Their Management
- (2009) Sarah M Gressett et al. ANNALS OF PHARMACOTHERAPY
- Pharmacology and therapeutic efficacy of capecitabine: focus on breast and colorectal cancer
- (2009) Giuseppe Aprile et al. ANTI-CANCER DRUGS
- NADPH Oxidases: Functions and Pathologies in the Vasculature
- (2009) Bernard Lassègue et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Pretreatment with Statin Attenuates the Cardiotoxicity of Doxorubicin in Mice
- (2009) A. Riad et al. CANCER RESEARCH
- Activated Forms of VEGF-C and VEGF-D Provide Improved Vascular Function in Skeletal Muscle
- (2009) Andrey Anisimov et al. CIRCULATION RESEARCH
- Adjuvant Trastuzumab Induces Ventricular Remodeling Despite Aerobic Exercise Training
- (2009) M. J. Haykowsky et al. CLINICAL CANCER RESEARCH
- Sunitinib-Induced Cardiotoxicity Is Mediated by Off-Target Inhibition of AMP-Activated Protein Kinase
- (2009) Risto Kerkela et al. CTS-Clinical and Translational Science
- Randomized, Double-Blind Trial of Carboplatin and Paclitaxel With Either Daily Oral Cediranib or Placebo in Advanced Non–Small-Cell Lung Cancer: NCIC Clinical Trials Group BR24 Study
- (2009) Glenwood D. Goss et al. JOURNAL OF CLINICAL ONCOLOGY
- Cardiovascular Complications of Cancer Therapy
- (2009) Edward T.H. Yeh et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Cardiotoxicity of Anticancer Drugs: The Need for Cardio-Oncology and Cardio-Oncological Prevention
- (2009) Adriana Albini et al. JNCI-Journal of the National Cancer Institute
- Metabonomic identification of novel biomarkers in doxorubicin cardiotoxicity and protective effect of the natural antioxidant oleuropein
- (2009) Ioanna Andreadou et al. NMR IN BIOMEDICINE
- Ranolazine combined with enalapril or metoprolol prevents progressive LV dysfunction and remodeling in dogs with moderate heart failure
- (2008) Sharad Rastogi et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Cardiotoxicity associated with the cancer therapeutic agent sunitinib malate
- (2008) M. L. Telli et al. ANNALS OF ONCOLOGY
- Heart failure associated with sunitinib malate
- (2008) Aarif Y. Khakoo et al. CANCER
- Cardiotoxicity of Antitumor Drugs†
- (2008) Pierantonio Menna et al. CHEMICAL RESEARCH IN TOXICOLOGY
- Prominent cardioprotective effects of third generation beta blocker nebivolol against anthracycline-induced cardiotoxicity using the model of isolated perfused rat heart
- (2008) Filomena de Nigris et al. EUROPEAN JOURNAL OF CANCER
- Blockade of the erbB2 Receptor Induces Cardiomyocyte Death through Mitochondrial and Reactive Oxygen Species-dependent Pathways
- (2008) Leo I. Gordon et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Left Ventricular Ejection Fraction and Cardiotoxicity: Is Our Ear Really to the Ground?
- (2008) Michael S. Ewer et al. JOURNAL OF CLINICAL ONCOLOGY
- Ventricular ErbB2/ErbB4 activation and downstream signaling in pacing-induced heart failure
- (2008) Kris Doggen et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Evaluation of the topoisomerase II-inactive bisdioxopiperazine ICRF-161 as a protectant against doxorubicin-induced cardiomyopathy
- (2008) Elke Martin et al. TOXICOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now